Holoeyes MD Receives Tokyo's Trial Certification for Innovative Medical Imaging Software
In a significant development for the medical imaging sector, Holoeyes Inc., based in Tokyo, has proudly announced that their innovative software, Holoeyes MD, has received formal recognition under the Tokyo Trial Certification system for the fiscal year 2028. This certification is particularly notable as it reinforces the platform's position as an essential tool in the realm of medical diagnostics, particularly in surgical areas where clarity and depth perception are crucial.
The Tokyo Trial Certification system is designed to support the proliferation of advanced products and services originating from small and medium-sized enterprises within the Tokyo metropolitan area. This initiative promotes exceptional new offerings that showcase significant novelty and efficacy, while also providing funding for a select few that the government intends to test in practical settings. The recognition of Holoeyes MD under this category comes as a beacon of promise for its potential impact on the medical landscape.
Surgeons often face inherent challenges when interpreting CT and MRI images, as traditional 2D displays provide limited depth perception. This can lead to complications that rely heavily on a physician's personal experiences and intuition. Holoeyes MD addresses such issues by leveraging advanced computer processing to transform medical images into 3D models within a metaverse environment. This capability facilitates a clearer understanding of spatial relations between organs, thus providing crucial insights that flat, 2D representations fail to deliver.
Since its medical device certification in 2020, Holoeyes has diligently pursued a path of technology development that is grounded in real-world application. They are committed to enhancing the quality and sustainability of healthcare, and this Tokyo Trial Certification is seen as a key milestone in these efforts. The company's CEO, Masaki Sugimoto, expressed pride in securing this recognition, viewing it as an endorsement of the XR technology's potential as a valuable asset in clinical environments.
"We are truly honored to receive this certification," Sugimoto remarked. "Holoeyes MD was developed to tackle the inefficiencies related to the sharing of information in medical settings, particularly by converting tacit knowledge into accessible, structured knowledge that can enhance quality, safety, and efficiency in healthcare. We believe that this recognition from Tokyo underscores the anticipated utility of XR technology in clinical practice. Furthermore, we aim to spatially reproduce and share medical insights and imaging data to further optimize healthcare delivery."
Holoeyes MD represents a breakthrough in medical imaging technology by enabling the conversion of CT and MRI images into 3D models compatible with cloud-based spatial computing. It enhances the representation of complex anatomical features, allowing healthcare professionals to visualize information that is typically obscured in a flat monitor setting. Primarily utilized within surgical fields, Holoeyes MD plays an essential role in diagnosis, treatment planning, and surgical simulation. Additionally, it serves as a resource for medical education and training.
The software's advantages are amplified through its capabilities to visualize intricate spatial structures through an intuitive XR interface, which supports multiple VR wearables to enhance the user experience.
Founded in 2016, Holoeyes Inc. is dedicated to optimizing healthcare through the spatial reproduction and sharing of medical imaging and insights. They have developed Holoeyes MD, alongside a range of VR applications aimed at training and clinical practices. Holoeyes continues to expand its reach domestically and internationally, with plans for upcoming services such as Holoeyes Biz, set to launch in late 2024, further promoting their mission to enhance medical technologies.
Contact Information:
Holoeyes Inc.
Location: 2-17-3 Minami Aoyama, 303 Morin Building, Minato-ku, Tokyo
Established: October 2016
CEO: Masaki Sugimoto
Capital: 100,000,000 JPY
Business Areas:
The Tokyo Trial Certification system is designed to support the proliferation of advanced products and services originating from small and medium-sized enterprises within the Tokyo metropolitan area. This initiative promotes exceptional new offerings that showcase significant novelty and efficacy, while also providing funding for a select few that the government intends to test in practical settings. The recognition of Holoeyes MD under this category comes as a beacon of promise for its potential impact on the medical landscape.
Surgeons often face inherent challenges when interpreting CT and MRI images, as traditional 2D displays provide limited depth perception. This can lead to complications that rely heavily on a physician's personal experiences and intuition. Holoeyes MD addresses such issues by leveraging advanced computer processing to transform medical images into 3D models within a metaverse environment. This capability facilitates a clearer understanding of spatial relations between organs, thus providing crucial insights that flat, 2D representations fail to deliver.
Since its medical device certification in 2020, Holoeyes has diligently pursued a path of technology development that is grounded in real-world application. They are committed to enhancing the quality and sustainability of healthcare, and this Tokyo Trial Certification is seen as a key milestone in these efforts. The company's CEO, Masaki Sugimoto, expressed pride in securing this recognition, viewing it as an endorsement of the XR technology's potential as a valuable asset in clinical environments.
"We are truly honored to receive this certification," Sugimoto remarked. "Holoeyes MD was developed to tackle the inefficiencies related to the sharing of information in medical settings, particularly by converting tacit knowledge into accessible, structured knowledge that can enhance quality, safety, and efficiency in healthcare. We believe that this recognition from Tokyo underscores the anticipated utility of XR technology in clinical practice. Furthermore, we aim to spatially reproduce and share medical insights and imaging data to further optimize healthcare delivery."
About Holoeyes MD
Holoeyes MD represents a breakthrough in medical imaging technology by enabling the conversion of CT and MRI images into 3D models compatible with cloud-based spatial computing. It enhances the representation of complex anatomical features, allowing healthcare professionals to visualize information that is typically obscured in a flat monitor setting. Primarily utilized within surgical fields, Holoeyes MD plays an essential role in diagnosis, treatment planning, and surgical simulation. Additionally, it serves as a resource for medical education and training.
The software's advantages are amplified through its capabilities to visualize intricate spatial structures through an intuitive XR interface, which supports multiple VR wearables to enhance the user experience.
Certification Details
- - General Name: Generic Image Diagnostic System Workstation Program
- - Product Name: Holoeyes MD
- - Classification: Class II (Managed Medical Device)
- - Certification Number: 302ADBZX00011000
- - Date of Certification: February 28, 2020
About Holoeyes Inc.
Founded in 2016, Holoeyes Inc. is dedicated to optimizing healthcare through the spatial reproduction and sharing of medical imaging and insights. They have developed Holoeyes MD, alongside a range of VR applications aimed at training and clinical practices. Holoeyes continues to expand its reach domestically and internationally, with plans for upcoming services such as Holoeyes Biz, set to launch in late 2024, further promoting their mission to enhance medical technologies.
Contact Information:
Holoeyes Inc.
Location: 2-17-3 Minami Aoyama, 303 Morin Building, Minato-ku, Tokyo
Established: October 2016
CEO: Masaki Sugimoto
Capital: 100,000,000 JPY
Business Areas:
- - Development and sales of medical imaging processing software
- - Provision of VR/AR platforms for medical enterprises
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.